# China, Macao SAR Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore China, Macao SAR HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: China, Macao SAR (MAC)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $36.2M
- Products: 20
- Buyer markets: 20
- Average CAGR: +9.3%
- Global sector size: $314.6B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $192.6B | $4.6M | $55.4B | -5.9% | 12 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $24.8B | $274.1K | $17.7B | +7.5% | 10 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $21.7B | $29.0M | $9.5B | -2.3% | 6 | +0.2% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $17.7B | $27.0K | $7.9B | -6.1% | 5 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.9B | $54.7K | $5.1B | -2.3% | 4 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $14.9B | $14.7 | $4.8B | +189.6% | 1 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $7.5B | $8.5 | $3.5B | +190.3% | 1 | +0.0% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $5.7B | $165.6K | $3.3B | +68.2% | 2 | +0.0% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $3.2B | $275.8 | $2.8B | -17.9% | 2 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $1.7M | $2.0B | +23.5% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $301.3K | $1.9B | +38.3% | 1 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $2.4B | $131.9 | $1.6B | -31.4% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $1.7B | $2.7K | $1.5B | +4.6% | 2 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $1.1B | $13.1K | $1.1B | +84.1% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $414.3 | $1.1B | +3.6% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $7.3K | $990.0M | -15.1% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $895.5M | $2.3K | $959.0M | -53.7% | 1 | +0.0% |
| HS 290511 - Alcohols: saturated monohydric, methanol (methyl alcohol) | $2.7B | $3.3K | $901.3M | +15.9% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $4.8K | $803.3M | +32.9% | 1 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $734.9M | $46.9K | $798.7M | -29.4% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $31.9B calculated opportunity across 6 products.
- China (CHN): $20.8B calculated opportunity across 10 products.
- Germany (DEU): $16.1B calculated opportunity across 5 products.
- United Kingdom (GBR): $8.8B calculated opportunity across 5 products.
- Canada (CAN): $6.9B calculated opportunity across 4 products.
- France (FRA): $6.5B calculated opportunity across 4 products.
- Netherlands (NLD): $5.3B calculated opportunity across 1 products.
- Spain (ESP): $5.2B calculated opportunity across 1 products.
- Taiwan (TWN): $4.1B calculated opportunity across 3 products.
- Ireland (IRL): $3.2B calculated opportunity across 1 products.
- Republic of Korea (KOR): $3.0B calculated opportunity across 2 products.
- India (IND): $2.7B calculated opportunity across 3 products.

## Growth stars

- HS 300212: +190.3% average CAGR, $3.5B calculated opportunity.
- HS 300215: +189.6% average CAGR, $4.8B calculated opportunity.
- HS 330210: +84.1% average CAGR, $1.1B calculated opportunity.
- HS 381800: +68.2% average CAGR, $3.3B calculated opportunity.
- HS 382319: +38.3% average CAGR, $1.9B calculated opportunity.
- HS 330290: +32.9% average CAGR, $803.3M calculated opportunity.
- HS 300420: +23.5% average CAGR, $2.0B calculated opportunity.
- HS 290511: +15.9% average CAGR, $901.3M calculated opportunity.
- HS 382499: +7.5% average CAGR, $17.7B calculated opportunity.
- HS 300290: +4.6% average CAGR, $1.5B calculated opportunity.

## Diversification opportunities

- HS 300490: 12 buyer markets, $55.4B calculated opportunity.
- HS 382499: 10 buyer markets, $17.7B calculated opportunity.
- HS 330499: 6 buyer markets, $9.5B calculated opportunity.
- HS 382200: 5 buyer markets, $7.9B calculated opportunity.
- HS 330300: 4 buyer markets, $5.1B calculated opportunity.
- HS 381800: 2 buyer markets, $3.3B calculated opportunity.
- HS 370790: 2 buyer markets, $2.8B calculated opportunity.
- HS 300290: 2 buyer markets, $1.5B calculated opportunity.
- HS 300215: 1 buyer markets, $4.8B calculated opportunity.
- HS 300212: 1 buyer markets, $3.5B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.